HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acid

structure given in first source; a chelating agent that can be conjugated to monoclonal antibodies
Also Known As:
CTPA
Networked: 307 relevant articles (13 outcomes, 53 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Kazerooni, Ella A: 7 articles (10/2015 - 06/2005)
2. Liu, Min: 7 articles (04/2015 - 01/2010)
3. Wang, Chen: 7 articles (04/2013 - 02/2009)
4. Szucs-Farkas, Zsolt: 5 articles (10/2014 - 01/2012)
5. Patel, Smita: 5 articles (01/2010 - 06/2005)
6. Kumamaru, Kanako K: 4 articles (12/2015 - 04/2012)
7. Rybicki, Frank J: 4 articles (12/2015 - 04/2012)
8. Hunsaker, Andetta R: 4 articles (12/2015 - 04/2012)
9. Henzler, Thomas: 4 articles (12/2015 - 01/2011)
10. Kline, Jeffrey A: 4 articles (04/2015 - 05/2010)

Related Diseases

1. Pulmonary Embolism
2. Pulmonary Hypertension (Ayerza Syndrome)
3. Venous Thromboembolism
4. Venous Thrombosis (Deep-Vein Thrombosis)
5. Embolism (Embolus)

Related Drugs and Biologics

1. fibrin fragment D (D-dimer)
2. glucuronyl glucosamine glycan sulfate (Vessel)
3. Gadolinium
4. Iodine
5. Contrast Media
6. Antigens
7. Biological Markers (Surrogate Marker)
8. Pulmonary venous return anomaly
9. Latex
10. Deoxycytidine (CDR)

Related Therapies and Procedures

1. Catheters
2. Withholding Treatment
3. Arthroplasty
4. Aftercare (After-Treatment)